ZYNERBA PHARMACEUTICALS, INC. Total Assets
ZYNERBA PHARMACEUTICALS, INC. had Total Assets of $40.48 million as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Assets
us-gaap:Assets · last filed 2023-08-14
- 2023-06-30: Assets $40.48M.
- 2023-03-31: Assets $48.64M.
- 2022-12-31: Assets $55.52M.
- 2022-09-30: Assets $62.37M.
| Period end | Assets |
|---|---|
| 2023-06-30 | $40.48M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $48.64M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $55.52M 10-Q · filed 2023-08-14 |
| 2022-09-30 | $62.37M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $67.01M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $74.38M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $81.17M 10-K · filed 2023-03-28 |
| 2021-09-30 | $90.00M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $98.20M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $108.81M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $74.06M 10-K · filed 2022-03-01 |
| 2020-09-30 | $77.21M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $87.48M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $76.47M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $87.76M 10-K · filed 2021-03-10 |
| 2019-09-30 | $94.32M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $95.57M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $75.52M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $67.33M 10-K · filed 2020-03-10 |
| 2018-09-30 | $72.93M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $52.20M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $59.90M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $69.05M 10-K · filed 2019-03-11 |
| 2017-09-30 | $73.07M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $79.09M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $84.70M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $36.55M 10-K · filed 2018-03-12 |
| 2016-09-30 | $36.29M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $35.80M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $39.10M 10-Q · filed 2016-05-12 |
| 2015-12-31 | $43.64M 10-K · filed 2017-03-27 |
| 2015-09-30 | $47.10M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $9.48M 10-Q · filed 2015-08-27 |
| 2014-12-31 | $11.62M 10-K · filed 2016-03-14 |